We are part of the CSL Limited group of companies. See how we're Driven by Our Promise.
We collaborate with rare disease organizations to promote quality medical care and services.
We offer a variety of support programs and activities for the patients we serve.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.
We work every day as if someone’s life depends on it, because it does.
We manufacture products to treat a number of rare diseases.
Help us deliver on our promise to save lives and protect the health of people.
Diversity and inclusion are top priorities for CSL Behring.
Working to Improve Diversity in Clinical Trials
CSL Behring joins a consortium of leading companies to raise awareness of clinical trials for all.
Rev Up Your Biotech Career With the 4 'R's
Be ready, relentless, resourceful and resilient, Bill Mezzanotte, CSL Behring’s Head of R&D and Chief Medical Officer, tells …
Seeking Researchers in Bleeding Disorders
Applications are open for CSL Behring’s Heimburger Awards, which provide funding for coagulation research.
Harnessing the 'Spirit of Innovation'
CSL Behring opens its first Philadelphia lab at University City Science Center.
Accessing Early Innovation in Europe
Research initiative connects CSL Behring with early-stage biotech ventures.
Machine Learning and a Slippery Prognosis
A Google subsidiary invites data scientists to crowd-solve big problems, like predicting lung function decline in patients wi…
Three Quotes About an Unprecedented Year
When CSL Limited announced its end-of-year results, company leaders took stock of where we’ve been and where we’re headed.
Watch: Advice for Young Scientists
Our Chief Scientific Officer offers words of wisdom for-up-and coming researchers.
Celebrating Scientific Innovation in Philadelphia
CSL Behring-sponsored Nucleus Awards honor region’s groundbreakers.
CSL’s New Chief Scientific Officer
Dr. Andrew Nash has a lot on his plate, but he really wants to see your latest data.
Careful Steps Into a New Normal
One of CSL Behring's newest innovation centers in Bern, Switzerland, springs back to full life, with COVID-19 precautions in …
Making a Digital Push for Clinical Trials
Clinical research leaders take awareness campaigns online to maintain momentum amid pandemic.
Popular search terms:
Americas
Asia Pacific
Europe
